NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2
Pushkal Sinduvadi Ramesh(JSS Academy of Higher Education and Research), Rajesh K. Thimmulappa(Johns Hopkins University)
Cited by 1
Related Papers
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
|Journal of Clinical Investigation|2006|1k
Role of Oxacillin Susceptibility Testing Strategy in Changing Scenario of mecA Positive Staphylococcus aureus Isolates (OS-MRSA) Detection
|Journal of Pure and Applied Microbiology|2023|1